Molecular Evaluation of Endometrial Dedifferentiated Carcinoma, Endometrioid Carcinoma, Carcinosarcoma, and Serous Carcinoma Using a Custom-Made Small Cancer Panel

<jats:p>It is often difficult to histologically differentiate among endometrial dedifferentiated carcinoma (DC), endometrioid carcinoma (EC), serous carcinoma (SC), and carcinosarcoma (CS) due to the presence of solid components. In this study, we aimed to categorize these carcinomas according to The Cancer Genome Atlas (TCGA) classification using a small custom-made cancer genome panel (56 genes and 17 microsatellite regions) for integrated molecular diagnosis. A total of 36 endometrial cancer cases with solid components were assessed using IHC, next-generation sequencing (NGS), and the custom-made panel. Among 19 EC cases, six were categorized as MMR-deficient (MMR-d) and eight were classified as having a nonspecific molecular profile. Three EC cases were classified as <jats:italic>POLE</jats:italic> mutation (<jats:italic>POLE</jats:italic>mut)-type, which had a very high tumor mutation burden (TMB) and low microsatellite instability (MSI). Increased TMB and MSI were observed in all three DC cases, classified as MMR-d with mutations in <jats:italic>MLH1</jats:italic> and <jats:italic>POLD1</jats:italic>. Except for one case classified as MMR-d, all SC cases exhibited <jats:italic>TP53</jats:italic> mutations and were classified as p53 mutation-type. SC cases also exhibited amplification of <jats:italic>CCND1</jats:italic>, <jats:italic>CCNE1</jats:italic>, and <jats:italic>MYC</jats:italic>. CS cases were classified as three TCGA types other than the <jats:italic>POLE</jats:italic>mut-type. The IHC results for p53 and ARID1A were almost consistent with their mutation status. NGS analysis using a small panel enables categorization of endometrial cancers with solid proliferation according to TCGA classification. As TCGA molecular classification does not consider histological findings, an integrated analytical procedure including IHC and NGS may be a practical diagnostic tool for endometrial cancers.</jats:p>